2016
DOI: 10.1016/j.bbrc.2016.06.046
|View full text |Cite
|
Sign up to set email alerts
|

Decreased HCRP1 promotes breast cancer metastasis by enhancing EGFR phosphorylation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(11 citation statements)
references
References 16 publications
0
11
0
Order By: Relevance
“…Previous studies revealed that loss of chromosome 8p, where VPS37A is located, promotes tumor growth (Cai et al, 2016;Xue et al, 2012). Decreased expression of VPS37 paralogs may be particularly beneficial for cells of advanced stage CRC as RNAi-mediated silencing of VPS37A promoted the resistance of prostate and breast cancer cells to chemotherapeutics (Sun et al, 2017;Yang et al, 2016). Our interrogation of TCGA expression data did not reveal increased transcription of CDKN1A, CDKN2B and CDKN2D in the advanced stages of CRC patients.…”
Section: Discussionmentioning
confidence: 58%
See 2 more Smart Citations
“…Previous studies revealed that loss of chromosome 8p, where VPS37A is located, promotes tumor growth (Cai et al, 2016;Xue et al, 2012). Decreased expression of VPS37 paralogs may be particularly beneficial for cells of advanced stage CRC as RNAi-mediated silencing of VPS37A promoted the resistance of prostate and breast cancer cells to chemotherapeutics (Sun et al, 2017;Yang et al, 2016). Our interrogation of TCGA expression data did not reveal increased transcription of CDKN1A, CDKN2B and CDKN2D in the advanced stages of CRC patients.…”
Section: Discussionmentioning
confidence: 58%
“…Another layer of complexity is added by the incorporation of Vps37 proteins into ESCRT-I to form functionally distinct complexes in the cell (Stefani et al, 2011;Wunderley et al, 2014). Changes in mRNA and protein levels of VPS37A were previously documented in various cancer types, including liver, prostate, breast, ovarian, renal, lung, glioma, gastric, oral and oropharyngeal squamous cell carcinoma and colon cancer (Chen et al, 2015;Chen et al, 2020;Chen et al, 2018;Du et al, 2016;Fu et al, 2018;Lai et al, 2009;Perisanidis et al, 2013;Sun et al, 2017;Vasaikar et al, 2019;Wittinger et al, 2011;Wu et al, 2019;Xu et al, 2017a;Xu et al, 2017b;Xu et al, 2014;Xu et al, 2017c;Xu et al, 2003;Yang et al, 2016;Yang et al, 2017;Zhu et al, 2015). Several of these studies suggested that VPS37A acts as a tumor suppressor and its loss can serve as an adverse prognostic factor.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…In HCC, downregulation of VPS37A promoted hepatocellular carcinoma cell migration and invasion by induction of EGFR activation and epithelial-mesenchymal transition [ 41 , 42 ]. In breast cancer, VPS37A was downregulated and inhibited breast cancer metastasis through downregulating EGFR phosphorylation [ 43 ]. In this study, we found VPS37A overexpression could significantly inhibit cell proliferation and promote cell apoptosis in PCa cells.…”
Section: Discussionmentioning
confidence: 99%
“…HCRP1 was first described as a growth inhibitory protein in HCC cells (5). Thereafter, additional physiologic functions of HCRP1 were explored in other tumors such as ovarian, oral and oropharyngeal, breast, and non-small cell lung cancer (6)(7)(8)(9)(10). HCRP1 is a member of the endosomal sorting complex required for transport (ESCRT)-Ι complex and affects lysosomal sorting of EGFR (11).…”
Section: Introductionmentioning
confidence: 99%